-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On November 29, Buchang Pharmaceuticals announced that its wholly-owned subsidiary Shandong Danhong's parecoxib sodium for injection was approved for listing
Parecoxib is a non-steroidal anti-inflammatory drug.
According to data from Menet.
Sales of Parecoxib on the terminal of public medical institutions in China (unit: ten thousand yuan)
Source: Mi Nei.
In addition to the original research manufacturer Pfizer, there are currently 30 domestic pharmaceutical companies approved to produce parecoxib sodium for injection, of which 24 companies have been reviewed, including Qilu Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, Hengrui Pharmaceutical, Bu Long pharmaceutical and so on
Buchang Pharmaceutical passed/deemed passed consistency evaluation varieties
Source: Mi Nei Net Consistency Evaluation Database
In recent years, Buchang Pharmaceutical has made frequent efforts in the field of chemical medicine
Data source: Minet database, company announcement